Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Romania. It operates through Consumer Health, Pharma, and Medical Devices segments. The company offers natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Preg, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Solal, and Vitaforce brand names. It also provides medical devices, and diagnostic laboratory equipment and consumables under the Reuterina, Pharmachem, Sinucon, Phlexy, Clonam, Surgical Innovations, RCA, and The Scientific Group brands. It also exports its products. The company serves pharmacies, private hospitals, and doctors, as well as government. The company was incorporated in 2008 and is based in Sandton, South Africa.
Stock data | 2023 | Change |
---|---|---|
Price | $0.04159437507300382 | N/A |
Market Cap | $26.04M | N/A |
Shares Outstanding | 626.05M | 30.48% |
Employees | 0 | N/A |
Shareholder Equity | 562.90M | 40.09% |
Valuation | 2023 | Change |
---|---|---|
P/S Ratio | 0.30 | N/A |
P/B Ratio | 0.05 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0076 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $87.49M | N/A |
Earnings | $4.29M | N/A |
Gross Margin | 0.3937 | N/A |
Operating Margin | -0.1286 | N/A |
Net income margin | 0.0491 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $55.31M | N/A |
Total Debt | $2.88M | N/A |
Cash on Hand | $5.93M | N/A |
Debt to Equity | 0.0413 | -77.18% |
Cash to Debt | $2.06 | 441.90% |
Current Ratio | $1.97 | 84.74% |